RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CARDONE C
Collezione AO Ordine Mauriziano

Items : 4

Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial. in International journal of cancer / Int J Cancer. 2023 Oct 15;153(8):1520-1528. doi: 10.1002/ijc.34632. Epub 2023 Jun 30.

2023
AO Ordine Mauriziano

Napolitano S; Ciardiello D; De Falco V; Martini G; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Fazio N; Di Maio M; Del Tufo S; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Jul 1;9(7):966-970. doi: 10.1001/jamaoncol.2023.0655.

2023
AO Ordine Mauriziano

Napolitano S; De Falco V; Martini G; Ciardiello D; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Bordonaro R; Scartozzi M; Santini D; Di Maio M; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. in ESMO open / ESMO Open. 2020 Mar;5(2):e000759. doi: 10.1136/esmoopen-2020-000759.

2020
AO Ordine Mauriziano

Lambertini M; Toss A; Passaro A; Criscitiello C; Cremolini C; Cardone C; Loupakis F; Viscardi G; Meattini I; Dieci MV; Ferrara R; Giusti R; Di Maio M;

The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings. in JAMA oncology / JAMA Oncol. 2020 Jun 1;6(6):926-927. doi: 10.1001/jamaoncol.2020.0475.

2020
AO Ordine Mauriziano

Di Maio M; Audisio M; Cardone C; De Luca E; Gargiulo P; Zichi C; Perrone F;